The CDR Tracker® is a subscription service that follows drugs through Canada's Common Drug Review (CDR) reimbursement approval process to listings on the public drug plans. Up to 5 people per organization can register under one subscription.

CDR Tracker® provides detailed information on CDR submissions including summaries of Canadian Expert Drug Advisory Committee (CEDAC) recommendations, listing dates on public drug plans, times to listing and much more. Subscriber can generate their own customer reports or choose from a number of predefined reports from our new website www.cdrtracker.com. The data are updated regularly.

This is essential information for those tracking competitors or planning to bring new drugs into Canada.